Virginia’s ATCC forged a long-term strategic collaboration with U.S. Pharmacopeia to jointly provide co-branded reference materials and reference standards to improve the quality and development of biologic medicines and therapies.
U.S. Pharmacopeia Medicine Supply Map releases global API manufacturing findings
U.S. Pharmacopeia (USP), an independent scientific organization, announces the USP Medicine Supply Vulnerability Insights Series sourced from USP’s global Medicine Supply Map. The first of its kind, the USP Medicine Supply Map leverages insights derived from the use of USP quality standards in more than 22 thousand locations around the world, spanning 92 percent of generic medicines approved in the US.
5 Questions with Natalie McKinney, Industry Programs Director, Biologics, US Pharmacopeia
Natalie McKinney is a marketing strategy leader with 15+ years of experience in life sciences and technology organizations. She uses data-driven, customer-centric approaches to gain a deep understanding of dynamic customer needs and drivers. She enjoys leveraging internal and external relationships to build a holistic customer view and gains alignment on high-impact, right-sized product and marketing investments that are timed appropriately for the market.